22^nd Global Biomarkers and Clinical Research Summit

Welcome Message

Dear Esteemed Participants,

On behalf of the organizing committee, it is our great honor to welcome you to the 22^nd Global Biomarkers and Clinical Research Summit, scheduled for August 27–28, 2026, in Paris, France.

This prestigious summit brings together researchers, clinicians, academicians, pharmaceutical and biotechnology professionals, and industry experts from across the globe to explore the latest advancements in biomarker discovery, translational research, and precision medicine. The theme for this year, “Translating Biomarker Discovery into Clinical Breakthroughs,” reflects our commitment to bridging the gap between laboratory innovation and real-world clinical application.

With biomarkers revolutionizing diagnosis, prognosis, and therapeutic monitoring across diseases, this summit serves as a dynamic platform to foster collaboration, share insights, and accelerate the integration of biomarkers into patient-centered healthcare.

Whether you are presenting new findings, participating in discussions, or seeking collaborations, we encourage you to make the most of this opportunity to contribute to and shape the future of biomarker research.

We look forward to welcoming you to Paris for two days of enriching discussions, innovation, and global networking.

Warm regards,
Organizing Committee

About Conference

The 22^nd Global Biomarkers and Clinical Research Summit will convene on August 27–28, 2026, in Paris, France, bringing together leaders from academia, research institutions, pharmaceutical companies, and clinical laboratories to discuss innovations shaping the future of biomedical science.

This summit offers a comprehensive platform for exploring the discovery, validation, and clinical translation of biomarkers across oncology, neurology, cardiology, immunology, and metabolic disorders. Attendees will gain valuable insights into omics technologies, digital biomarkers, clinical assay development, regulatory frameworks, and biomarker-guided drug discovery.

The 2026 edition will feature keynote sessions from globally recognized experts, interactive symposia, workshops, oral and poster presentations, and panel discussions on emerging opportunities and challenges in clinical biomarker integration. Designed to promote collaboration between academia and industry, this event bridges innovation with implementation — turning scientific breakthroughs into real-world healthcare solutions.

Whether you are a scientist advancing molecular discoveries, a clinician applying biomarkers to personalized treatment, or a biotech innovator driving diagnostic technologies, this summit is your global stage to engage, learn, and lead.

CONFERENCE AGENDA:

Registration & Kit Collection: Delegates begin by collecting conference kits, name badges, and agendas. Staff will be available to assist and guide participants through the event schedule.

Inaugural Session & Opening Remarks: The summit opens with welcoming remarks from the organizing committee, followed by keynote lectures from distinguished leaders in biomarker science and translational medicine.

Scientific Sessions & Presentations: Parallel sessions will cover a broad range of topics, including biomarker validation, proteomics, metabolomics, clinical assay development, companion diagnostics, and regulatory pathways. Oral and poster presentations will showcase pioneering studies and industry-driven innovations.

Networking Breaks & Exhibitions: Coffee breaks and poster walks offer valuable opportunities to meet peers, discuss research, and explore exhibitor displays from diagnostics, pharma, and biotech organizations.

Conference Lunch & Award Ceremony: Delegates will enjoy interactive lunches and networking discussions. Awards will be presented for the best oral and poster presentations on the concluding day.

Optional Activities: Participants may join guided tours or networking dinners, blending scientific collaboration with the cultural charm of Paris. 

Why to Attend?

Attending this conference offers a blend of knowledge, networking, and opportunity:

• Gain deep insights into the latest global biomarkers and clinical research strategies and innovations.
• Engage with decision-makers, researchers, and clinical research leaders from across Europe and beyond.
• Strengthen professional networks to support collaborations, research partnerships, and institutional linkages.
• Present your work to an international audience and enhance your academic and professional visibility.
• Access sessions focused on cutting-edge topics such as biomarker validation, proteomics, metabolomics, clinical assay development, companion diagnostics, and regulatory pathways.
• Participate in workshops that translate evidence into practice, offering tools that can be implemented in real-world settings.

Experience the cultural richness of Paris while being part of one of Europe’s most impactful health conferences.

Participation / Presentation Options

To ensure accessibility for global researchers and clinical professionals, the Summit offers multiple participation formats designed to support scientific exchange, visibility, and collaboration.

Oral Presentation: Showcase comprehensive studies, clinical trial findings, biomarker discovery research, molecular diagnostics, or innovative laboratory methodologies. Oral presenters participate in interactive Q&A sessions with scientific experts.

Poster Presentation: Ideal for early-stage studies, pilot data, method development, and exploratory biomarker work. Presenters engage with delegates during dedicated poster viewing and networking segments.

Virtual Presentation: A flexible option for participants unable to travel. Present your work online and receive equal recognition, certificates, and publication benefits as onsite presenters.

Delegate Participation: For professionals who wish to attend without presenting. Delegates gain full access to all scientific sessions, keynote talks, workshops, and networking activities.

Exhibitor & Sponsorship Opportunities: Designed for biotech firms, diagnostic companies, CROs, universities, and healthcare technology providers. Exhibitors can showcase products, services, and innovations to a global audience.

Participation Benefits

Knowledge Enhancement & Skill Development:

• Learn from global leaders in biomarkers, precision medicine, molecular diagnostics, and translational research.
• Gain insights from keynote lectures, scientific sessions, expert panels, and hands-on workshops.
• Explore advancements in multi-omics, liquid biopsy technologies, AI-driven diagnostics, and clinical data science.

Global Networking Opportunities:

• Meet researchers, clinicians, industry experts, and innovators from over 40 countries.
• Build partnerships for joint projects, publications, grants, and institutional collaborations.
• Connect with peers, mentors, and future employers in both academic and industrial settings.

Presentation & Publication Advantages:

• Present your research through Oral, Poster, or Virtual formats.
• Receive:
• Certificate of Presentation
• Certificate of Participation
• Official conference recognition
• Selected abstracts may be included in conference proceedings or associated publications.
• Early submissions receive priority scheduling and enhanced visibility.

Career Growth & Professional Development:

• Strengthen your academic profile and CV with participation in a globally recognized summit.
• Gain insights into clinical research trends, biomarker validation workflows, and regulatory pathways.
• Attend sessions on scientific leadership, research communication, and healthcare innovation.

Diverse Session Formats:

• Keynote sessions
• Scientific oral presentations
• Poster exhibitions
• Panel debates
• Specialized technical workshops
• Industry demonstrations

Each session is designed to encourage interactive learning and cross-disciplinary collaboration.

Resources & Post-Conference Access:

• Access recorded sessions (virtual and select categories).
• Download speaker presentations, session summaries, and conference materials.
• Continue networking through post-event communication channels.

Visa Assistance & Flexible Participation:

• Receive official invitation letters for visa processing.
• If travel is not possible, participants may switch to virtual mode or transfer registration as per policy.
• Hybrid options ensure participation regardless of travel restrictions.

Institutional & Organizational Benefits:

• Enhance institutional visibility through international representation.
• Explore collaboration opportunities with global research groups and industry partners.
• Identify new technologies, clinical tools, and research advancements for institutional growth.

Cultural & Experiential Value (Onsite Participants):

• Experience Paris—its culture, science, cuisine, and historic landmarks.
• Take part in networking dinners, social gatherings, and optional city tours.
• Combine scientific enrichment with a memorable international travel experience.

Certification & Recognition:

All participants receive:

• Certificate of Participation
• Certificate of Presentation (for presenters)
• Official endorsement from the 22^nd Global Biomarkers and Clinical Research Summit

These recognitions support academic portfolios, job applications, and future grant proposals.

Abstract Review Process

Our abstract review process ensures academic rigor and fair evaluation:

Submission: Authors submit abstracts through the official online portal.

Pre-Screening: The editorial team verifies topic relevance, clarity, and structure.

Double-Blind Evaluation: Each abstract is reviewed by two independent experts specializing in biomarkers and clinical research, or related fields.

Scoring Criteria:

• Scientific merit and originality
• Practical implications for biomarkers
• Methodological accuracy
• Relevance to conference themes

Decision & Notification: Accepted abstracts are assigned to Oral, Poster, or Virtual Presentation categories. Feedback and revision suggestions may be offered where applicable.

Early Acceptance Advantage: Early submissions are given priority in program scheduling, allowing authors to secure preferred presentation slots.

VISA Process

We support all international participants in successfully completing their visa application process. Once your registration is confirmed, the organizing committee will provide:

• A formal Invitation Letter
• Accommodation confirmation (if booked through the conference)
• A detailed conference schedule
• Proof of registration and payment

These documents assist in meeting the requirements of the French Embassy or Consulate in your region.

General Visa Requirements:

Participants may be asked to provide:

• A valid passport
• Completed visa application form
• Invitation letter from the conference
• Proof of accommodation and travel itinerary
• Registration confirmation

We strongly recommend applying 6–8 weeks in advance to avoid last-minute complications.

In Case of Visa Rejection: Refund & Participation Options:

We understand that visa outcomes vary from country to country. Therefore, our policy is designed to support you:

• If your visa is rejected, you may switch to Virtual Presentation or Virtual Participation without any deduction.
• If you prefer to request a refund, the organizing committee will process it after receiving the official visa rejection letter from the embassy or consulate.
• Refund requests must be submitted within 10 days of receiving the rejection notice.
• Processing timelines for refunds are typically 2–3 weeks.
• Registration can also be transferred to the next edition of the conference without additional fees if preferred.

This ensures that your research and contribution remain part of the scientific program—even if you cannot travel physically.

Market Analysis

The global biomarkers market continues to grow rapidly, driven by the increasing demand for precision medicine, early disease detection, and targeted therapeutics.

• The global biomarkers market is projected to surpass USD 180 billion by 2030, growing at a CAGR of over 12%.
• Cancer biomarkers dominate the sector, with rising applications in immunotherapy and liquid biopsy technologies.
• Neurological and cardiovascular biomarkers are witnessing significant investment due to advancements in imaging and omics-based diagnostics.
• AI and machine learning are transforming data integration and biomarker discovery pipelines, enabling predictive analytics in clinical decision-making.
• Pharmaceutical and biotech collaborations are expanding, focusing on companion diagnostics and drug development efficiency.

This summit provides an ideal platform for researchers, investors, and industry leaders to align with emerging market trends, foster global partnerships, and accelerate translational biomarker research from bench to bedside.